Ajanta Pharma reports 21% fall in Q1 consolidated net profit

09 Aug 2017 Evaluate

Ajanta Pharma has reported results for first quarter ended June 30, 2017. 

The company has reported a fall of 23.20% in its net profit at Rs 76.73 crore for the quarter under review as compared to Rs 99.91 crore for the same quarter in the previous year. Total income of the company decreased by 5.56% at Rs 402.63 crore for Q1FY18 as compared Rs 426.35 crore for the corresponding quarter previous year. 

On the consolidated basis, the company has reported a fall of 20.71% in its net profit at Rs 94.79 crore for the quarter under review as compared to Rs 119.55 crore for the same quarter in the previous year. Total income of the company decreased marginally by 0.72% at Rs 477.88 crore for Q1FY18 as compared Rs 481.36 crore for the corresponding quarter previous year.

Ajanta Pharma Share Price

2638.75 12.50 (0.48%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×